U.S. STOCKS ON THE MOVE-Tesla, New York Community Bancorp, GlobalFoundries
Genprex rises on dosing first patient in mid-stage cancer study
Brief: Genprex Announces First Patient Dosed In Phase 2A Expansion Of Acclaim-1
Brief: Genprex Says Co Poised for FDA Guidance On Diabetes Gene Therapy Program In 2024
Brief: Genprex Entered Into An At Market Offering Agreement
Novavax shares fall for second day; EMA decision on its COVID shot expected in Oct
Brief: Genprex Appoints Suzanne Thornton-Jones As Senior Vice President, Regulatory Affairs
Brief: Genprex Announces Closing Of $7.5 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: Genprex Announces $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
Genprex up on agreement with the University of Pittsburgh
Brief: Genprex Signs Exclusive License To Additional Diabetes Technology With University Of Pittsburgh
Brief: Genprex Granted Chinese Patent For REQORSA Immunogene Therapy In Combination With PD-1 Antibodies To Treat Cancers
U.S. STOCKS ON THE MOVE-Louisiana-Pacific, Jefferies Financial Group, Beazer Homes
U.S. STOCKS ON THE MOVE-Netflix, Genprex, Joby Aviation
Genprex rises on FDA's 'fast-track' tag for lung cancer therapy
Brief: Genprex Receives U.S. FDA Fast Track Designation For Small Cell Lung Cancer Treatment
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty